Stable lenalidomide oral solid preparation

A technology of lenalidomide and solid preparations, which is applied in the field of pharmaceutical preparations, can solve the problems of changing appearance and color, affecting the stability of preparations, and increasing the impurity content of solid oral preparations, achieving improved stability, low impurity content, and high solubility Effect

Active Publication Date: 2010-08-04
NANJING CAVENDISH BIO ENG TECH +1
4 Cites 20 Cited by

AI-Extracted Technical Summary

Problems solved by technology

[0009] Because lenalidomide is insoluble in water, it affects the dissolution rate of its oral solid preparation and then directly affects the bioavailability of the drug. The prior art solves this problem by micronization or strong salt; in addition, the oral solid preparation auxiliary material The type may affect the stability of the preparation. For example, due to the...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Abstract

The invention discloses a lenalidomide oral solid preparation which is based on 10000 solid preparation units and is prepared by the following components: 10-500g of lenalidomide, 300-1200g of premixed powder, 50-200g of cross-linked sodium carboxymethyl cellulose, 1-50g of magnesium stearate and 100-500ml of 10% (percent weight in volume) povidone absolute ethyl alcohol solution, wherein the premixed powder is the mixture of lactose and microcrystalline cellulose which have the weight ratio of 2:3. In addition, the invention also discloses a preparation method of the lenalidomide oral solid preparation and usage thereof. The lenalidomide oral solid preparation has the advantages that a sample can be reserved for a long time with stable quality; and the lenalidomide oral solid preparation can be released within a short time so as to be easily absorbed by the human body completely.

Application Domain

Technology Topic

Image

  • Stable lenalidomide oral solid preparation
  • Stable lenalidomide oral solid preparation
  • Stable lenalidomide oral solid preparation

Examples

  • Experimental program(4)
  • Comparison scheme(2)
  • Effect test(1)

Example Embodiment

[0082] Example 1
[0083] 5mg lenalidomide capsules
[0084] Premix powder prescription
[0085] Lactose 3000g
[0086] Microcrystalline cellulose 2000g
[0087] 5000g in total
[0088] Attachment: Preparation of adhesive (10% povidone ethanol solution):
[0089] Povidone K30 200g
[0090] Add absolute ethanol to 2000ml
[0091] Capsule prescription
[0092] Lenalidomide 50g
[0093] Premixed accessories 800g
[0094] Croscarmellose Sodium 100g
[0095] 10% povidone ethanol solution 350ml
[0096] Magnesium stearate 10g
[0097] Filled with 10,000 grains
[0098] Preparation:
[0099] (1) Preparation of adhesive Weigh 100g of povidone K30, put it in a 1000ml beaker, add an appropriate amount of absolute ethanol, stir to dissolve, add absolute ethanol to 1000ml, stir well, and set aside.
[0100] (2) Take lactose and microcrystalline cellulose, crush them and pass through a 100-mesh sieve, and mix them evenly according to the prescription of premixed auxiliary materials to obtain premixed auxiliary materials for use.
[0101] (3) Take croscarmellose sodium, crush it and pass it through a 100-mesh sieve for use.
[0102] (4) Take Nalidomide, smash it and pass it through a 100-mesh sieve for use.
[0103] (5) Weigh the pre-mixed excipients, croscarmellose sodium and lenalidomide according to the capsule prescription, and mix them evenly to obtain the drug-containing mixed powder for use.
[0104] (6) Add a binder to the medicine-containing mixed powder to prepare 16 mesh wet granules, and dry them at 40°C to obtain dry granules.
[0105] (7) After the dry granules are sized through an 18-mesh sieve, magnesium stearate is added and mixed with the dry granules to obtain intermediate granules.
[0106] (8) Determination of the intermediate particle content, and calculate the amount based on the content.
[0107] (9) Adjust the volume and fill the capsule.
[0108] (10) Packing to get finished product.

Example Embodiment

[0109] Example 2
[0110] 10mg lenalidomide capsules
[0111] The premixed powder prescription is the same as in Example 1
[0112] Capsule prescription
[0113] Lenalidomide 100g
[0114] Premixed accessories 750g
[0115] Croscarmellose Sodium 100g
[0116] 10% povidone ethanol solution 350ml
[0117] Magnesium stearate 10g
[0118] Filled with 10,000 grains
[0119] Preparation method: the same as in Example 1.

Example Embodiment

[0120] Example 3
[0121] 25mg lenalidomide capsules
[0122] The premixed powder prescription is the same as in Example 1
[0123] Capsule prescription
[0124] Lenalidomide 250g
[0125] Premixed accessories 600g
[0126] Croscarmellose Sodium 100g
[0127] 10% povidone ethanol solution 350ml
[0128] Magnesium stearate 10g
[0129] Filled with 10,000 grains
[0130] Preparation method: the same as in Example 1.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

no PUM

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Similar technology patents

New compound ramification of garcinia acid

InactiveCN1563014AImprove stabilityImprove solubilityOrganic chemistryNitro compound active ingredientsChemistryAcid derivative
Owner:HANGZHOU MINSHENG PHARM CO LTD

New technique for preparing cellulose carbate through urea embedding method

InactiveCN1687137AExtend activation timeImprove solubilityChemistryUrea
Owner:XINJIANG TECHN INST OF PHYSICS & CHEM CHINESE ACAD OF SCI

Classification and recommendation of technical efficacy words

  • Low impurity content
  • Improve solubility

Method for preparing gasoline and diesel by oil washing hydrogenation

InactiveCN101486926ABig increaseLow impurity contentRefining to eliminate hetero atomsCoal tarNaphtha
Owner:胜帮科技股份有限公司

Substituted pentacene semiconductors

InactiveUS6864396B2Stable and reproducible electronic performance characteristicImprove solubilityTransistorOrganic compound preparationHalogenBenzene
Owner:3M INNOVATIVE PROPERTIES CO

Method of preparing a polymer using aliphatic solutions of aminoalkyllithium compounds

InactiveUS6046288AIncreased insolubilityImprove solubilityLithium organic compoundsSolventPolymer
Owner:BRIDGESTONE CORP

Moldable poly(arylene ether) thermosetting compositions, methods, and articles

InactiveUS20030018131A1Difficult to handleImprove solubilitySolventEther
Owner:SABIC INNOVATIVE PLASTICS IP BV

Bamboo charcoal cellulose fiber and manufacturing method thereof

ActiveCN101104960AImprove solubilityHarm reductionArtificial filaments from cellulose solutionsIonNanometre
Owner:潍坊欣龙生物材料有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products